Physician profile
Erica S Harding
NPI 1538374236
$4,531.63
in general payments reported to CMS, 2019-2025
44 companies · $1,184 in 2025
The $1,184 reported for 2025 was more than what 96% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $455 · 2020: $283 · 2021: $508 · 2022: $586 · 2023: $767 · 2024: $748 · 2025: $1,184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,699.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,011.01 | 2021-2025 | |
| Novo Nordisk INC | $966.79 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $390.45 | 2019-2025 | Krystexxa, Evenity, Prolia |
| Pfizer INC. | $381.49 | 2019-2025 | |
| Lilly USA, LLC | $258.30 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $230.71 | 2022-2025 | Arexvy, Shingrix, Bexsero |
| Merck Sharp & Dohme LLC | $116.84 | 2019-2024 | Verquvo, Belsomra, Gardasil |
| Astellas Pharma US INC | $102.69 | 2022-2025 | Veozah |
| Daiichi Sankyo INC. | $80.38 | 2020-2024 | Injectafer |
| Philips North America LLC | $70.73 | 2023-2025 | (8874) Incourage, Vest Therapy Und |
| Astrazeneca Pharmaceuticals Lp | $66.49 | 2021-2025 | Airsupra, Breztri |
| Axsome Therapeutics, INC. | $55.21 | 2025 | Auvelity, Symbravo |
| Amarin Pharma, INC. | $47.17 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $47.12 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $46.92 | 2023 | Gvoke Hypopen |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erica Harding listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.